IGF2BP1 promotes endometriosis by enhancing m6A modification stability of HMGB1
Journal of Obstetrics and Gynaecology Research · 2025
DOI: 10.1111/jog.16242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2025. Verfasst von Xin Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Chin…. Hauptthemen laut MEDLINE: Endometriosis, HMGB1 Protein, RNA-Binding Proteins, Adenosine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Background
Endometriosis is a chronic inflammatory condition afflicting women of reproductive age. Our study aims to clarify the function and mechanism of insulin‐like growth factor 2 mRNA‐binding protein 1 (IGF2BP1) and high mobility group box 1 protein (HMGB1) in endometriosis.
Methods
HMGB1 and various N6‐methyladenosine (m6A) reader protein levels were assessed in normal, eutopic, and ectopic endometrial tissue, and a correlation analysis was conducted. The impact of IGF2BP1 knockdown on endometriosis was assessed both in vivo in rat models and in vitro in ectopic endometrial stromal cells (eESCs) using methods such as immunoblotting and mRNA quantification. The binding of IGF2BP1 to HMGB1 mRNA in eESCs was assessed using RIP‐PCR. Following transfection with sh‐IGF2BP1 and oe‐HMGB1, the expression of IGF2BP1 and HMGB1, as well as cell proliferation, invasion, and migration abilities, were measured in eESCs.
Results
In ectopic endometrial tissue, IGF2BP1 and HMGB1 were elevated and positively correlated. Inhibition of IGF2BP1 reduced eESC proliferation, migration, invasion, and glucose intake. Meanwhile, HMGB1, PKM2, and HK2 expression were depressed. In vivo, results were consistent with in vitro. Additionally, in vivo experiments confirmed that inhibition of IGF2BP1 resulted in reduced ectopic endometrial lesion spherical volume, weight, and interstitial lesions. IGF2BP1 bound to HMGB1 mRNA and enhanced its stability by m6A modification. Conversely, when IGF2BP1 was knocked down and HMGB1 was overexpressed, the results were opposite to those observed previously.
Conclusion
IGF2BP1 promotes endometriosis progression by enhancing m6A modification stability of HMGB1. This study provides a theoretical basis for identifying therapeutic targets for endometriosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China.
- Department of Ultrasound, Joint Logistics Support Force 921 Hospital, Changsha, China.
ORCID-Profile: Xin Wei
Förderung
- Natural Science Foundation of Hunan Province
Zitieren
APA
Wei, X., Su, Y., Tian, W., Cheng, L., Yin, L., & He, X. (2025). IGF2BP1 promotes endometriosis by enhancing m6A modification stability of HMGB1. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.16242
Vancouver
Wei X, Su Y, Tian W, Cheng L, Yin L, He X. IGF2BP1 promotes endometriosis by enhancing m6A modification stability of HMGB1. Journal of Obstetrics and Gynaecology Research. 2025. doi:10.1111/jog.16242
BibTeX
@article{Wei2025,
author = {Wei, Xin and Su, Yanlin and Tian, Wencai and Cheng, Li and Yin, Ling and He, Xiaoxia},
title = {IGF2BP1 promotes endometriosis by enhancing m6A modification stability of HMGB1},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2025},
doi = {10.1111/jog.16242}
}
EUVIMED